Asian Phytoceuticals PCL Cash Flow Statement

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	55.41	54.71	107.49	80.92	68.7
Depreciation & Amortization	19.55	20.5	21.98	23.13	26.81
Other Amortization	0.09	0.18	0.17	0.12	0.15
Loss (Gain) From Sale of Assets	-0.04	-2.12	-0.01	-0.12	-0.18
Loss (Gain) From Sale of Investments	-6.87	-1.73	-0.47	0.01	-2.51
Loss (Gain) on Equity Investments	-1.65	-1.67	-1.26	-0.61	0.28
Provision & Write-off of Bad Debts	-	-	-	0.34	-
Other Operating Activities	-0.97	-15.03	-13.94	-10.24	-8.64
Change in Accounts Receivable	1.27	-2.67	0.42	0.13	2.87
Change in Inventory	-13.05	-13.95	7.45	5.42	1.07
Change in Accounts Payable	1.55	0.21	3.12	1.62	-0.13
Change in Other Net Operating Assets	-3.08	-0.76	-0.86	-0.52	-4.03
Operating Cash Flow	52.22	37.67	124.1	100.18	84.4
Operating Cash Flow Growth	38.65%	-69.65%	23.87%	18.70%	-2.71%
Capital Expenditures	-0.8	-2.31	-3.37	-0.32	-1.17
Sale of Property, Plant & Equipment	0.04	2.12	0.01	0.12	0.42
Sale (Purchase) of Intangibles	-0.13	-	-0.72	-	-
Investment in Securities	51.36	7.49	16.87	-40.94	-6.13
Other Investing Activities	8.99	16	16.36	12.35	11.83
Investing Cash Flow	59.46	23.3	29.14	-28.78	4.95
Long-Term Debt Repaid	-14.39	-13.86	-15.07	-15.54	-18.14
Net Debt Issued (Repaid)	-14.39	-13.86	-15.07	-15.54	-18.14
Common Dividends Paid	-55.16	-107.93	-92.94	-73.99	-71.95
Other Financing Activities	-1.99	-2.45	-1.74	1.68	-0.86
Financing Cash Flow	-71.54	-124.23	-109.75	-87.84	-90.95
Net Cash Flow	40.14	-63.27	43.49	-16.45	-1.61
Free Cash Flow	51.42	35.36	120.72	99.86	83.22
Free Cash Flow Growth	45.44%	-70.71%	20.89%	19.99%	0.78%
Free Cash Flow Margin	25.69%	16.77%	41.24%	39.88%	37.26%
Free Cash Flow Per Share	0.08	0.06	0.20	0.17	0.14
Cash Interest Paid	1.13	1.59	0.66	0.57	0.86
Cash Income Tax Paid	10.15	18.31	26.81	19.78	17.75
Levered Free Cash Flow	41.31	29.03	99.28	87.31	74.42
Unlevered Free Cash Flow	42.31	30.03	99.7	87.66	74.96
Change in Working Capital	-13.3	-17.17	10.14	6.65	-0.22

Source: S&P Global Market Intelligence. Standard template. Financial Sources.